Tailored community engagement can build trust with underserved communities to deliver health equity. Comment from DrOdedina, Rafaela Alves Pacheco, and marciacastrorj, as part of our focus issue on Building Healthy Populations.
To foster optimal health for all, these health disparity factors can only be addressed effectively when the communities affected are fully engaged in developing
solutions for their community health. Community engagement is widely recognized as the key to building trust and a requirement for an effective academic–community partnership.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Large language models in medicine - Nature MedicineLarge language models in medicine: Our new Review from Daniel Shu Wei Ting & colleagues serves as a primer for interested clinicians, who will ultimately decide if and how LLM technology is used in healthcare. ChatGPT AI NUSingapore Cambridge_Uni
Les mer »
Balancing human and AI roles in clinical imaging - Nature MedicineNew data suggest that combining AI with human expertise could improve diagnostic accuracy while maintaining a safety net in clinical imaging. Read the News and Views from Fiona Gilbert fjg28_fiona Cambridge_Uni
Les mer »
The top 6 women’s shorts to wear all summer longFrom classic denim shorts to tailored options
Les mer »
U.S. Attorney's Office: UW Medicine to provide services to hearing impairedThe UW Medical Center will now be providing sign-language interpreters and other assistive devices for patients who are deaf or hard of hearing after getting a complaint from a patient that services were not provided to them in 2021.
Les mer »
SEPTA project will temporarily close Penn Medicine Station; Impact three Regional Rail lines🚆 🚧 A SEPTA construction project will cause service interruptions to several rail lines as well as temporarily close the Penn Medicine Station starting Saturday, July 22. See if you will be impacted here:
Les mer »
SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial - Nature MedicineAdoptive transfer of convalescent donor-derived SARS-CoV-2 -specific T cells was safe and conferred faster recovery in patients with severe COVID-19 compared with standard of care
Les mer »